Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This trial is a multi-site, randomized, open-label, parallel, and single-dose administration
study to investigate the safety and efficacy of TLC599 in subjects with osteoarthritis of the
knee.